You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 38 No. 12, December 1981 TABLE OF CONTENTS
  Archives
  •  Online Features
  BRIEF COMMUNICATIONS AND CLINICAL NOTES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Opsoclonic Cerebellopathy

A Paraneoplastic Syndrome Responsive to Thiamine

Paul A. Nausieda, MD; Caroline M. Tanner, MD; William J. Weiner, MD

Arch Neurol. 1981;38(12):780-781.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Cerebellar dysfunction associated with opsoclonic eye movements has been described as a paraneoplastic effect of malignant neoplasms and may be the initial symptom in some cases. This neurologic symptom complex is rare and has been reported in association with carcinomas of the lung,1.2 breast,3 and uterus4 in adults. In children, it is associated with neural crest tumors, particularly neuroblastoma.5-7 Like most paraneoplastic syndromes, the pathogenesis of this disorder is unknown. No specific therapy for this syndrome is known other than treatment of the underlying malignancy.

We studied a patient in whom an isolated subacute cerebellar syndrome and opsoclonus developed, which appeared 14 months after apparently successful chemotherapy of an oropharyngeal carcinoma. Although the initial clinical impression was that of paraneoplastic syndrome related to recurrence of the primary neoplasm, no evidence of recurrence was apparent. An empiric trial of thiamine hydrochloride led to dramatic improvement in clinical . . . [Full Text PDF of this Article]


Author Affiliations

From the Departments of Neurological Sciences (Drs Nausieda, Tanner, and Weiner) and Pharmacology (Drs Nausieda and Weiner), Rush-Presbyterian St Lukes Medical Center, Chicago.


Footnotes

Accepted for publication April 16, 1981.

Reprint requests to Department of Neurological Sciences, 1725 W Harrison St, Suite 915, Chicago, IL 60612 (Dr Nausieda).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.